Enlivex (ENLV) Other Operating Expenses (2015 - 2025)
Enlivex (ENLV) posted quarterly Other Operating Expenses of $1.3 billion for Q4 2025, up 142418.18% year-over-year from N/an in Q4 2024, and up 18114971.43% quarter-over-quarter from $7000.0 in Q2 2025.
Enlivex (ENLV) Other Operating Expenses (2015 - 2025) Analysis & Trends
Enlivex's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $1.3 billion for Q4 2025.
- In Q4 2025, Other Operating Expenses rose 142418.18% year-over-year to $1.3 billion; the TTM figure through Dec 2025 stood at $1.3 billion (up 183881.3% YoY), while the FY2025 annual figure was $1.3 billion, up 132606.17% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $1.3 billion, up from $7000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $1.3 billion in Q4 2025, with the low at -$891000.0 in Q4 2024.
- The 5-year median for Other Operating Expenses is $115000.0 (2024), against an average of $127.2 million.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 120.99% in 2024, then soared 142418.18% in 2025.
- Enlivex's Other Operating Expenses stood at $440000.0 in 2021, then slumped by 112.73% to -$56000.0 in 2022, then jumped by 7678.57% to $4.2 million in 2023, then plunged by 120.99% to -$891000.0 in 2024, then jumped by 142418.18% to $1.3 billion in 2025.
- Business Quant data shows ENLV's Other Operating Expenses at $1.3 billion in Q4 2025, $7000.0 in Q2 2025, and $29000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Bn |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | -891,000.00 |
| Sep 30, 2024 | -267,000.00 |
| Jun 30, 2024 | 267,000.00 |
| Mar 31, 2024 | 201,000.00 |
| Dec 31, 2023 | 4.24 Mn |
| Sep 30, 2022 | -56,000.00 |
| Sep 30, 2021 | 440,000.00 |
| Jun 30, 2017 | 65,000.00 |
| Mar 31, 2017 | 406,000.00 |
| Dec 31, 2016 | 875,000.00 |
| Sep 30, 2016 | 39,000.00 |
| Jun 30, 2016 | 64,000.00 |
| Mar 31, 2016 | 772,000.00 |
| Dec 31, 2015 | 563,000.00 |
| Sep 30, 2015 | 266,000.00 |